Order Article Reprints

Takhar P, Geirnaert M, Gavura S, Beca J, Mercer RE, Denburg A, Muñoz C, Tadrous M, Parmar A, Dionne F, et al. Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current Oncology. 2024; 31(4):1876-1898. https://doi.org/10.3390/curroncol31040141

Takhar, Pam, Marc Geirnaert, Scott Gavura, Jaclyn Beca, Rebecca E. Mercer, Avram Denburg, Caroline Muñoz, Mina Tadrous, Ambica Parmar, Francois Dionne, and et al. 2024. "Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration" Current Oncology 31, no. 4: 1876-1898. https://doi.org/10.3390/curroncol31040141

Takhar, P., Geirnaert, M., Gavura, S., Beca, J., Mercer, R. E., Denburg, A., Muñoz, C., Tadrous, M., Parmar, A., Dionne, F., Boehm, D., Chambers, C., Craig, E., Trudeau, M., Cheung, M. C., Houlihan, J., McDonald, V., Pechlivanoglou, P., Taylor, M., ... Chan, K. K. W. (2024). Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration. Current Oncology, 31(4), 1876-1898. https://doi.org/10.3390/curroncol31040141